Company: IMNN
Filing Date: 2025-05-30
Form Type: S-1
Source: 0001641172-25-013088
Chunk: 35

Company: Imunon, Inc.
Filing Date: 2025-05-30
Form: S-1
Chunk 35
---
 10.31   |     | Form of Securities Purchase Agreement, dated May 23, 2025, incorporated by reference to Exhibit 10.1 to the Current Report on Form 8-K of the Company filed on May 27, 2025 (SEC File No. 001-15911).                                                                                                                                                                                                                                                                                                  |

| II-6 |

| 10.32 |     | Form of Registration Rights Agreement, dated May 23, 2025, incorporated by reference to Exhibit 10.2 to the Current Report on Form 8-K of the Company filed on May 27, 2025 (SEC File No. 001-15911). |
| 21.1  |     | Subsidiaries of Imunon, Inc., incorporated by reference to Exhibit 21.1 to the Annual Report on Form 10-K of the Company for the year ended December 31, 2024 (SEC File No. 001-15911).               |
| 23.1+ |     | Consent of WithumSmith+Brown, PC, independent registered public accounting firm for the Company.                                                                                                      |
| 23.2+ |     | Consent of Thompson Hine LLP (included in Exhibit 5.1).                                                                                                                                               |
| 24.1+ |     | Power of Attorney (included on signature page).                                                                                                                                                       |
| 107+  |     | Filing Fee Table.                                                                                                                                                                                     |

| *  |     | Portions                                                                                                                           
 of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act 
 of 1934, amended, and the omitted material has been separately filed with the Securities and Exchange Commission.                  |
| ** |     | Management                                                                                                                         
 contract or compensatory plan or arrangement.                                                                                      |
| +  |     | Filed                                                                                                                              
 herewith.                                                                                                                          |

Item 17. Undertakings

(a) The undersigned registrant hereby undertakes:

(1) To file, during any period in which offers or sales are being made, a post-effective amendment to this registration statement:

(i) To include any prospectus required by section 10(a)(3) of the Securities Act of 1933;

(ii) To reflect in the prospectus any facts or events arising after the effective date of the registration statement (or the most recent post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set